DE3326165C2 - - Google Patents

Info

Publication number
DE3326165C2
DE3326165C2 DE3326165A DE3326165A DE3326165C2 DE 3326165 C2 DE3326165 C2 DE 3326165C2 DE 3326165 A DE3326165 A DE 3326165A DE 3326165 A DE3326165 A DE 3326165A DE 3326165 C2 DE3326165 C2 DE 3326165C2
Authority
DE
Germany
Prior art keywords
dds
leprosy
brodimoprim
combination
cultures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3326165A
Other languages
German (de)
English (en)
Other versions
DE3326165A1 (de
Inventor
Joachim Karl 2061 Borstel De Seydel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE3326165A1 publication Critical patent/DE3326165A1/de
Application granted granted Critical
Publication of DE3326165C2 publication Critical patent/DE3326165C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19833326165 1982-07-29 1983-07-20 Pharmazeutisches praeparat Granted DE3326165A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4600/82A CH651473A5 (de) 1982-07-29 1982-07-29 Pharmazeutisches praeparat.

Publications (2)

Publication Number Publication Date
DE3326165A1 DE3326165A1 (de) 1984-04-12
DE3326165C2 true DE3326165C2 (fr) 1993-07-22

Family

ID=4279115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833326165 Granted DE3326165A1 (de) 1982-07-29 1983-07-20 Pharmazeutisches praeparat

Country Status (8)

Country Link
JP (1) JPS5933218A (fr)
BE (1) BE897397A (fr)
CH (1) CH651473A5 (fr)
DE (1) DE3326165A1 (fr)
FR (1) FR2531861B1 (fr)
GB (1) GB2125293B (fr)
IT (1) IT1171692B (fr)
NL (1) NL194535C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK387687A (da) * 1986-07-28 1988-01-29 Warner Lambert Co Fremstilling af farmaceutisk praeparat til behandling af infektioner med mycobacterium avium-intracellulare komplekset

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK136470B (da) * 1973-11-08 1977-10-17 Hoffmann La Roche Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
ZW10681A1 (en) * 1980-06-26 1982-02-24 Hoffmann La Roche Antibacterial agents
GB2082063A (en) * 1980-08-15 1982-03-03 Haughey Edward Antibacterial drug

Also Published As

Publication number Publication date
FR2531861B1 (fr) 1987-08-28
GB2125293A (en) 1984-03-07
CH651473A5 (de) 1985-09-30
NL8302579A (nl) 1984-02-16
NL194535B (nl) 2002-03-01
DE3326165A1 (de) 1984-04-12
IT8322089A0 (it) 1983-07-15
IT1171692B (it) 1987-06-10
NL194535C (nl) 2002-07-02
JPH0419968B2 (fr) 1992-03-31
GB8320438D0 (en) 1983-09-01
JPS5933218A (ja) 1984-02-23
FR2531861A1 (fr) 1984-02-24
IT8322089A1 (it) 1985-01-15
BE897397A (fr) 1984-01-30
GB2125293B (en) 1985-11-13

Similar Documents

Publication Publication Date Title
DE69122298T2 (de) Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung
DE69026620T2 (de) Anti-tumor-zubereitung enthaltend interleukin-2 und histamin, analoge dazu oder h2-rezeptor-agonisten
DD241271A5 (de) Verfahren zur unterscheidung von normalen und boesartigen zellen in einer mischung in vitro
DE69725879T2 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
US4256743A (en) Inhibition of bone resorption with H1 -blocking antihistamines
DE3205018C2 (de) Verwendung von Cyclodextrin als Bifidobakterien vermehrendes Mittel
DE69819012T2 (de) Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
DE60032915T2 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
DE2048375A1 (de) Wirksammachung von Antibiotika
EP2047855B1 (fr) Composition antitumorale, antibactérienne et antivirale (et variantes)
DE3916417C2 (fr)
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
DE3326165C2 (fr)
DE60104977T2 (de) Glucosamin enthaltende Neutrophil-Funktionshemmer
EP0214933A2 (fr) Préparations à base de mélanges pour le traitement de la malaria
EP1001756B1 (fr) Compositions a effet synergique pour lutter selectivement contre les tissus tumoraux
DE2728589C3 (de) Verwendung von 2-(2,2-disubstituierten)-Äthylimidazolinen bei der Bekämpfung von Diabetes
EP1096947B1 (fr) Medicament topique pour le traitement d'infections virales
DE3117756C2 (fr)
EP0820771A2 (fr) Composition pharmaceutique pour le traitement de neuropathies contenant une thiamine liposoluble et un composé de magnésium
DE69214979T2 (de) Neue, dietätische Zubereitungen auf Basis von Phosphor-Lipidkomplexen sowie deren Verwendung bei Schlafstörungen
DE2755017C2 (fr)
DE60124732T2 (de) Gatifloxacin als inhibitor der cytokinproduktion
DE60203895T2 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie

Legal Events

Date Code Title Description
OR8 Request for search as to paragraph 43 lit. 1 sentence 1 patent law
8105 Search report available
8127 New person/name/address of the applicant

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8128 New person/name/address of the agent

Representative=s name: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDER

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee